TAM
RGLS

Tocqueville Asset Management’s Regulus Therapeutics RGLS Stock Holding History

Tocqueville Asset Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-944
Closed -$374K – 846
2016
Q3 		$374K Sell
944
-7
-0.7% -$2.88K ﹤0.01% 676
2016
Q2 		$330K Sell
951
-161
-14% -$115K ﹤0.01% 707
2016
Q1 		$925K Sell
1,112
-32
-3% -$25.5K 0.01% 514
2015
Q4 		$1.2M Sell
1,144
-31
-3% -$31.1K 0.02% 509
2015
Q3 		$922K Buy
1,175
+802
+215% +$823K 0.01% 576
2015
Q2 		$490K Buy
373
+140
+60% +$226K 0.01% 724
2015
Q1 		$473K Sell
233
-97
-29% -$211K 0.01% 727
2014
Q4 		$635K Buy
+330
New +$587K 0.01% 661
2014
Q3 		– Sell
-571
Closed -$551K – 1178
2014
Q2 		$551K Buy
571
+38
+7% +$32.6K 0.01% 699
2014
Q1 		$577K Buy
533
+233
+78% +$258K 0.01% 545
2013
Q4 		$266K Buy
300
+42
+16% +$36.2K ﹤0.01% 739
2013
Q3 		$292K Buy
+258
New +$304K ﹤0.01% 780

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Tocqueville Asset Management's RGLS Position: Q4 2016 in Review

Tocqueville Asset Management sold out of Regulus Therapeutics (RGLS) in Q4 2016, closing a stake of 944 shares — an estimated $374K sold.

Tocqueville Asset Management first reported a position in RGLS in Q3 2013 and held it in 12 quarters. The position peaked at $1.2M in Q4 2015. 68 funds tracked by Wall St. Rank hold RGLS as of Q4 2016.

  • Tocqueville Asset Management reported no remaining Regulus Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Tocqueville Asset Management sold 944 Regulus Therapeutics shares in Q4 2016, an estimated $374K.
  • Tocqueville Asset Management first reported a position in Regulus Therapeutics in Q3 2013 and held it in 12 quarters.
  • Tocqueville Asset Management's Regulus Therapeutics position peaked at $1.2M in Q4 2015.
  • 68 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.